Arcadium Lithium plc|4/AJan 12, 10:36 AM ET

Antoniazzi Gilberto 4/A

4/A · Arcadium Lithium plc · Filed Jan 12, 2024

Form 4/AAmended

Period: 2024-01-04

CFO, VP & Treasurer

Transactions

Award
Stock Option (Right to Buy)
2024-01-04+41,715→ 41,715 total
Exercise: $3.45From: 2020-02-27Exp: 2027-02-27→ Ordinary Shares (41,715 underlying)
Award
Stock Option (Right to Buy)
2024-01-04+28,246→ 28,246 total
Exercise: $3.92From: 2018-02-27Exp: 2025-02-27→ Ordinary Shares (28,246 underlying)
Award
Stock Option (Right to Buy)
2024-01-04+103,113→ 103,113 total
Exercise: $7.07From: 2021-10-10Exp: 2028-10-10→ Ordinary Shares (103,113 underlying)
Award
Stock Option (Right to Buy)
2024-01-04+24,849→ 28,849 total
Exercise: $5.10From: 2021-02-15Exp: 2028-02-15→ Ordinary Shares (28,849 underlying)
Award
Stock Option (Right to Buy)
2024-01-04+103,116→ 103,116 total
Exercise: $7.07From: 2022-10-10Exp: 2028-10-10→ Ordinary Shares (103,116 underlying)

Footnotes (2)

[F1]The original Form 4, filed on January 8, 2024, is being amended by this Form 4 amendment to correct an error which omitted these tranches from the list of stock options to purchase common stock of Livent Corporation ("Livent"), par value $0.001 per share ("Livent Options") beneficially owned by the reporting person as of January 4, 2024 and converted in accordance with the terms of the Transaction Agreement, dated as of May 10, 2023, by and between Livent, Allkem Limited ("Allkem"), Lightning-A Merger Sub, Inc. and Arcadium, providing for a combination of Livent and Allkem in a merger of equals transaction (as amended, the "Transaction Agreement")
[F2]Represents the conversion of Livent Options into stock options to purchase ordinary shares of Arcadium Lithium plc ("Arcadium"), par value $1.00 per share ("Arcadium Options"), in accordance with the terms of the Transaction Agreement, in connection with the merger of equals transaction.

Documents

1 file